NCT05150535

One Week Adjuvant Radiotherapy for Breast Cancer

A Prospective Study of One Week Accelerated Hypo-fractionation Adjuvant Radiotherapy in High-risk Breast Cancer Patients

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Sohag University · Academic / Other
• Sex: Female
• Age: 45 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

* Cancer is the second leading cause of death after cerebrovascular strokes and is a significant obstacle to each nation's future growth. * Worldwide, Breast cancer is the most common cancer in women and the 5th leading cause of cancer related deaths that comes after lung cancer, colorectal cancer, liver cancer and gastric cancer. * More than half of all breast cancer cases in the world occur in developing countries. Egypt has a high mortality rate from breast cancer, with a rate of 21.3 per 100,000 cases. Breast cancer is diagnosed at an advanced stage in 60 to 70% of cases in Egypt. The median age at diagnosis in Egypt is 48.5 years, which seems to be a decade younger than in Europe and North America.

Conditions

• Breast Carcinoma

Interventions

Type	Name	Description
RADIATION	Hypofractionation Radiotherapy.	Patients will receive 40 Gy in 15 fractions to the entire breast and or chest wall over the course of 3 weeks.
RADIATION	Ultra-hypofractionation radiotherapy	Patients will receive 26 Gy in 5 fractions to the entire breast and or chest wall over the course of one week.

Timeline

• Start date: 2021-10-01
• Primary completion: 2023-10-01
• Completion: 2023-10-01
• First posted: 2021-12-09
• Last updated: 2022-05-09

Locations

1 site across 1 country: Egypt